Author

P. Klekotka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Heaps· 2 shared C. Moser· 2 shared D. A. Wohl· 2 shared D. M. Smith· 2 shared E. S. Daar· 2 shared J. J. Eron· 2 shared J. Ritz· 2 shared J. S. Currier· 2 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Heaps

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintNov 21, 2023

SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback

C. H. Coelho, N. Bloom, S. I. Ramirez…·Accelerating COVID-19 Therapeutic Interventions and Vaccines: 2/A5401 (ACTIV-2/A5401) Study Team

This study shows that SARS-CoV-2 mAb treatment shifts memory B cell epitope recognition, affecting their response to vaccination.

DOI 10.1101/2023.11.21.567575

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintOct 25, 2023

Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2

S. I. Ramirez, P. G. Lopez, F. Faraji…·ACTIV-2/A5401 Study Team

The paper examines early T cell and antibody responses in COVID-19 patients and finds they correlate with reduced SARS-CoV-2 viral RNA in the upper respiratory tract.

DOI 10.1101/2023.10.25.564014

humanbulk RNA-seq

𝕏 PostBluesky